| Michael Kenji Yamazaki, MD | |
|
888 S King St, Bone And Joint Center, Honolulu, HI 96813-3097 | |
| (808) 522-2639 | |
| (808) 522-4401 |
| Full Name | Michael Kenji Yamazaki |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 18 Years |
| Location | 888 S King St, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639359813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | A101393 (California) | Secondary |
| 208100000X | Physical Medicine & Rehabilitation | 15519 (Hawaii) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Straub Clinic And Hospital | Honolulu, HI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Straub Clinic And Hospital | 6305759754 | 404 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism - symptoms typical of Parkinson's disease like body tremors and slowing of body motions - after the toxin travels from the stomach to the brain.
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
Patients taking benzodiazepines to treat psychiatric conditions should consider transitioning to other therapies because of heightened risks for dementia and death, according to clinicians from the American College of Osteopathic Neurologists and Psychiatrists.
› Verified 1 days ago
| Entity Name | Straub Clinic & Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306508 PECOS PAC ID: 6305759754 Enrollment ID: O20031111000417 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism - symptoms typical of Parkinson's disease like body tremors and slowing of body motions - after the toxin travels from the stomach to the brain.
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
Patients taking benzodiazepines to treat psychiatric conditions should consider transitioning to other therapies because of heightened risks for dementia and death, according to clinicians from the American College of Osteopathic Neurologists and Psychiatrists.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Kenji Yamazaki, MD 888 S King St, Bone And Joint Center, Honolulu, HI 96813-3097 Ph: (808) 522-2639 | Michael Kenji Yamazaki, MD 888 S King St, Bone And Joint Center, Honolulu, HI 96813-3097 Ph: (808) 522-2639 |
News Archive
Forest Laboratories, Inc., an international pharmaceutical manufacturer and marketer and Nycomed, a privately owned pharmaceutical company, today announced that results of four phase III trials have been published in the prestigious peer-reviewed medical journal The Lancet showing that roflumilast, a phosphodiesterase 4 (PDE4) inhibitor, improved lung function and reduced exacerbations in patients with moderate to severe COPD.
The first view of the physical mechanism of how a blood clot contracts at the level of individual platelets is giving researchers from the Perelman School of Medicine at the University of Pennsylvania a new look at a natural process that is part of blood clotting.
Combining low doses of a toxic herbicide with sugar-binding proteins called lectins may trigger Parkinsonism - symptoms typical of Parkinson's disease like body tremors and slowing of body motions - after the toxin travels from the stomach to the brain.
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
Patients taking benzodiazepines to treat psychiatric conditions should consider transitioning to other therapies because of heightened risks for dementia and death, according to clinicians from the American College of Osteopathic Neurologists and Psychiatrists.
› Verified 1 days ago
Won-yee Cheng-leever, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2828 Paa St, Honolulu, HI 96819 Phone: 808-432-5777 | |
Dr. Maria B. Patten, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2828 Paa St, Honolulu, HI 96819 Phone: 808-432-7450 | |
Dr. Timothy Joseph Roe, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 226 N Kuakini St, Honolulu, HI 96817 Phone: 808-566-3471 | |
Dr. Daniel Shawn Burdick, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 226 N Kuakini St, Honolulu, HI 96817 Phone: 808-531-3511 | |
Miss Diana Mun Wah Lee, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 226 N Kuakini St, Honolulu, HI 96817 Phone: 808-544-3310 | |
April Michelle Brewster, LPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 615 Piikoi St, Honolulu, HI 96814 Phone: 808-591-6068 | |
Dr. Amendeep K Somal, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 226 N Kuakini St, Honolulu, HI 96817 Phone: 808-566-3460 Fax: 808-535-1572 |